eFFECTOR Therapeutics, Inc.

OTCPK:EFTR Stock Report

Market Cap: US$940.0

eFFECTOR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:EFTR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Nov 23SellUS$369,457SR One Capital Management, LPCompany24,366.52US$15.16

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EFTR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders47,1621%
Public Companies75,1521.6%
Institutions241,9055.14%
General Public4,340,19092.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 82%.


Top Shareholders

Top 13 shareholders own 7.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
2.4%
Altitude Life Science Ventures
113,054US$22.60%100.0%
1.6%
Pfizer Inc.
75,152US$15.00%no data
1.31%
Sabby Management, LLC
61,758US$12.3-82.5%no data
1.11%
Blackstone Inc.
52,343US$10.50%no data
0.74%
Stephen Worland
34,987US$7.00%no data
0.31%
Pfizer Venture Investments LLC
14,602US$2.90%no data
0.15%
Christopher Ehrlich
7,136US$1.40%no data
0.066%
Michael Byrnes
3,117US$0.60%no data
0.026%
Brian Gallagher
1,200US$0.20%no data
0.0077%
Caroline Loewy
361US$0.070%no data
0.0077%
Elizabeth Bhatt
361US$0.070%no data
0.0021%
Barclays Bank PLC, Securities Investments
100US$0.020%no data
0.001%
Manulife Investment Management (North America) Limited
48US$0.010%no data